Home > Boards > US Listed > Medical - Drugs > Lipocine Inc (LPCN)

If the news was good with the NASH

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
BesaoT35 Member Profile
 
Followed By 2
Posts 635
Boards Moderated 0
Alias Born 07/08/13
160x600 placeholder
Lipocine EPS beats by $0.01 Seeking Alpha - 11/10/2021 8:09:09 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/10/2021 8:04:08 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/10/2021 8:01:52 AM
Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2021 PR Newswire (US) - 11/10/2021 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/9/2021 8:01:41 AM
Lipocine shares jump 9% after FDA Fast Track status for LPCN 1144 NASH treatment Seeking Alpha - 11/4/2021 8:29:25 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/4/2021 8:01:36 AM
Lipocine Announces FDA Grants Fast Track Designation to LPCN 1144 for Treatment of Non-Cirrhotic NASH PR Newswire (US) - 11/4/2021 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/1/2021 5:26:16 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/1/2021 8:01:29 AM
Lipocine Announces Multiple Poster Presentations at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2021 PR Newswire (US) - 11/1/2021 8:00:00 AM
FCEL, INFI and SIOX among pre market gainers Seeking Alpha - 10/18/2021 8:15:44 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/18/2021 7:01:27 AM
Lipocine And Antares Pharma Enter Into U.S. Licensing Agreement To Commercialize TLANDO® PR Newswire (US) - 10/18/2021 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/12/2021 3:32:08 PM
Lipocine to Present at The H.C. Wainwright 5th Annual NASH Investor Conference PR Newswire (US) - 10/5/2021 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/28/2021 8:01:20 AM
Lipocine Announces FDA Affirmation Of Class 1 NDA Resubmission For TLANDO® PR Newswire (US) - 9/28/2021 8:00:00 AM
Lipocine to Present at The Cantor Fitzgerald Virtual Global Healthcare Conference PR Newswire (US) - 9/20/2021 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/13/2021 8:02:02 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/10/2021 5:02:10 PM
Lipocine to Present at The H.C. Wainwright 23rd Annual Global Investment Conference PR Newswire (US) - 9/1/2021 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/25/2021 6:36:12 AM
Lipocine's LPCN 1144 Met Non-Alcoholic Steatohepatitis ("NASH") Resolution Regulatory Endpoint in Phase 2 LiFT Study PR Newswire (US) - 8/25/2021 6:30:00 AM
Lipocine EPS misses by $0.03 Seeking Alpha - 8/5/2021 9:05:16 AM
BesaoT35   Thursday, 08/26/21 12:09:05 PM
Re: None
Post # of 759 
If the news was good with the NASH data why is the stock flat to down?

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences